Skip to main content
Signal8

NEIS JOHN

SEC insider (Form 3/4/5 filer). CIK 0001167426. Director at Cellectar Biosciences, Inc. (CLRB). 3 reported Form 4/5 transactions since Sep 2024; latest on Jul 7, 2026. Located in FLORHAM PARK, NJ.

Companies NEIS JOHN has filed insider reports for

  • Cellectar Biosciences, Inc. (CLRB): Director
NEIS JOHN profile photo

NEIS JOHN

CIK: 0001167426

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Cellectar Biosciences, Inc. logo
CLRB

Cellectar Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Cellectar Biosciences, Inc. logo
    CLRB

    Cellectar Biosciences, Inc.

    Jul 7, 2026
    Award

    Stock option (right to buy)

    Direct
    25K shares-
  • Cellectar Biosciences, Inc. logo
    CLRB

    Cellectar Biosciences, Inc.

    Dec 12, 2025
    Sale
    Indirect
    198 shares at avg. $3.70$731.986
  • Cellectar Biosciences, Inc. logo
    CLRB

    Cellectar Biosciences, Inc.

    Feb 14, 2025
    Award

    Stock option (right to buy)

    Direct
    60K shares-

1-3 of 3